WallStSmart
PYXS

Pyxis Oncology Inc

NASDAQ: PYXS · HEALTHCARE · BIOTECHNOLOGY

$1.70
+2.41% today

Updated 2026-04-30

Market cap
$106.81M
P/E ratio
P/S ratio
7.71x
EPS (TTM)
$-1.28
Dividend yield
52W range
$1 – $6
Volume
0.4M

WallStSmart proprietary scores

25
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C
5.0
Quality
C+
2.5
Profitability
F
4.0
Valuation
C
/9
Piotroski F-Score
Altman Z-Score
Industry rank
View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target
$6.88
+304.71%
12-Month target
Intrinsic (DCF)
$0.95
Margin of safety
-42.11%
1 Strong Buy7 Buy1 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-10.43M
- 42.11% above intrinsic value

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$0.00$0.00$16.15M$13.86M$13.86M
Net income$-117.95M$-73.79M$-77.33M$-79.62M$-18.11M
EPS$-1.28
Free cash flow$-95.73M$-77.44M$-57.91M$-63.51M$-10.43M
Profit margin-478.95%-574.55%

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
PYXS$106.81M254.32.54.05.0-42.11%Avoid
LLY$760.43B7810.010.05.06.5Strong Buy
JNJ$547.28B594.79.03.36.0-43.54%Buy
ABBV$360.63B634.08.04.75.0-29.31%Buy
UNH$336.47B545.35.57.34.8+42.09%Buy
AZN$287.11B646.78.05.35.0+4.07%Buy

Smart narrative

Pyxis Oncology Inc trades at $1.70. Our Smart Value Score of 25/100 indicates the stock is weak. TTM revenue stands at $13.86M. Our DCF model estimates intrinsic value at $0.95.

Frequently asked questions

What is Pyxis Oncology Inc's stock price?
Pyxis Oncology Inc (PYXS) trades at $1.70.
Is Pyxis Oncology Inc overvalued?
Smart Value Score 25/100 (Grade F, Strong Sell). DCF value $0.95.
What is the price target of Pyxis Oncology Inc (PYXS)?
The analyst target price is $6.88, representing +304.7% upside from the current price of $1.70.
What is the intrinsic value of Pyxis Oncology Inc (PYXS)?
Based on our DCF model, intrinsic value is $0.95, a -42.1% margin of safety versus $1.70.
What is Pyxis Oncology Inc's revenue?
TTM revenue is $13.86M.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio7.71x
ROE-91.40%
Beta1.42
50D MA$1.54
200D MA$2.16
Shares out0.06B
Float0.04B
Short ratio
Avg volume0.4M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years